These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26822381)

  • 1. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy.
    Jayalakshmi S; Vooturi S; Sahu S; Yada PK; Mohandas S
    J Clin Neurosci; 2016 Apr; 26():89-94. PubMed ID: 26822381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit.
    Vooturi S; Jayalakshmi S; Sahu S; Mohandas S
    Clin Neurol Neurosurg; 2014 Nov; 126():7-10. PubMed ID: 25194304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiology and outcome of generalized convulsive status epilepticus in elderly.
    Jayalakshmi S; Vooturi S; Chepuru R; Sahu S; Surath M
    Seizure; 2015 Jul; 29():104-8. PubMed ID: 26076851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus.
    Jayalakshmi S; Patil A; Challa A; Parekh M; Khandelia H; Vooturi S
    J Clin Neurosci; 2022 Mar; 97():12-16. PubMed ID: 35030458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile and outcome of refractory convulsive status epilepticus in older children from a developing country.
    Lingappa L; Konanki R; Patel R; Vooturi S; Jayalakshmi S
    Seizure; 2016 Mar; 36():31-35. PubMed ID: 26889778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very high dose phenobarbital for refractory status epilepticus.
    Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
    J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.